The ASCO-SITC Clinical Immuno-Oncology Symposium is a three-day meeting focused on clinical and translational research in immuno-oncology and the implications for clinical care.
This meeting addresses the high-level of need for clinical education in a field where all aspects of care are fundamentally different from traditional therapies.
Why Should you Attend this Meeting?
-
CONNECT: Meet faculty members and fellow attendees from around the world in both formal and informal networking events.
-
DISCOVER: Attend education and science sessions that explore pioneering clinical and translational research and breakthroughs in immuno-oncology and its implications for patient care.
-
ENGAGE: Ask expert faculty your most pressing questions in extended Question and Answer panels. Visit the exhibits to expand your understanding of the most advanced therapies, products, and upcoming research.
-
GET CREDIT: Earn CME credit and MOC points from ABIM and ABAI for attending the Symposium.
SITC OrganizersMario Sznol, MD* –
Yale Cancer Center (SITC President)Lawrence Fong, MD* –
University of California San FranciscoHussein Tawbi, MD, PhD* –
MD Anderson Cancer CenterMichael Sadelain, MD, PhD –
Memorial Sloan Kettering Cancer CenterMadhav V. Dhodapkar, MBBS* –
Emory UniversityJennifer A. Wargo, MD, MMSc* –
MD Anderson Cancer CenterASCO OrganizersStephen Gottschalk, MD* –
St. Jude Children's Research HospitalKunle Odunsi, MD, PhD* –
Roswell Park Comprehensive Cancer CenterRobert Dreicer, MD, MS, MACP, FASCO –
University of Virginia Cancer CenterDung T. Le, MD –
Johns Hopkins UniveristyAllison Betof-Warner, MD, PhD –
Memorial Sloan Kettering Cancer CenterEdward B. Garon, MD, MS* –
University of California Los Angeles*Denotes SITC MemberTo find out more information, please click here.